Ablative Solutions
PrivateLast Round
Series D
Dec 26, 2024
Total Funding Raised
$155.66M
Company Overview
Ablative Solutions is a medical device company that develops catheter-based neurolytic delivery systems for the treatment of uncontrolled hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablative Solutions Comparables
Compare Ablative Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vascular Dynamics, Inc. | 87% | |
| Cortex, Inc. | 85% | |
| DeepQure | 81% |
Ablative Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 26, 2024 | ||||
| Early Stage VC | Jan 30, 2024 | ||||
| Series D | Jun 13, 2022 | ||||
| Series C | Jan 3, 2018 | ||||
| Series B | Feb 4, 2014 | ||||
Series A | Jun 19, 2012 |
Ablative Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioStar Equity | Series B, Series A |
| Gilde Healthcare | Series D |
| Invus Opportunities | Series D |
| Charter Capital Partners | Series D, Series B, Series A |
| BioStar Capital | Series A, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2024
$29.3M raised in early stage VC funding.
- Feb 4, 2014
$9.5M round led by BioStar Equity.
Ablative Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ablative Solutions's valuation, stock price, and market status.
Is Ablative Solutions a public or private company?
Ablative Solutions is a private company.
What is the current stock price of Ablative Solutions?
Ablative Solutions is a private company with no public stock price. No recent secondary market data is available.
How much is Ablative Solutions worth (valuation)?
Valuation information for Ablative Solutions is not publicly available.
Can I buy Ablative Solutions stock?
Ablative Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ablative Solutions's last funding round?
Ablative Solutions's most recent funding round was Series D on December 26, 2024.
Who are the main investors in Ablative Solutions?
Key investors in Ablative Solutions include BioStar Equity, Gilde Healthcare, Invus Opportunities, BioStar Capital.
Will Ablative Solutions IPO soon?
No public IPO plans have been announced for Ablative Solutions.
How can I track Ablative Solutions secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ablative Solutions's secondary market activity and sign up for updates.